Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaNew England Journal of MedicineSeptember 11, 201710.1056/nejmoa1709684Cited by 5,392SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis